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Following the original description of erythema chroniicum migrans (ECM) in Sweden in
1909, ECM became widely recognized in Europe. The first reported case of ECM acquired in
the United States occurred in 1969, and in 1975 the full symnptom complex nlow kniowni as Lyme
disease was recognized. In 1981, cases of Lyme disease were recogniized in yet a third conitinienlt,
Australia and, to date, cases acquired in at least 19 counitries have been reported. Beginning
with the original case reported in Sweden, clinical observations suggested that Ixodes ricinus
ticks were a vector for ECM in Europe and the distribution of cases in Europe corresponids to
the distribution of this tick, although one case outside this range has been reported following
mosquito bites. Through similar observations, L dammini and I. pacificus ticks have been
established as vectors in the United States. In Australia, a vector has not beeni established, anid
none of the recognized vectors of Lyme disease occur there. The reportinig of cases of Lyme
disease from widely separated parts ofthe world involving multiple vectors suggests the disease
may, in the future, be recognized in additional areas.
Erythema chronicum migrans (ECM), the skin lesion characteristic of Lyme
disease, was originally described by Afzelius in Sweden in 1909 [1]. Subsequently,
ECM has been recognized in at least 18 additional countries on three continents.
Before the recognition of ECM in the United States in 1969 [2] and in Australia in
1981 [3], however, ECM was well described, and the vector identified, in the Euro-
pean literature.
Afzelius, in his original description, noted that the disease had occurred after a
tick bite. A tick vector was also recognized by subsequent European investigators
and this tick was identified as Ixodes ricinus, widely distributed in Europe from the
coastal areas of Scandinavia to northern Spain and northern Italy in the south [4].
At least one case of ECM, however, acquired in northern Sweden outside the
recognized distribution of I. ricinus, has been ascribed to a mosquito vector [5]. In
the United States, the recognized vectors are L dammini and L pacificus [6], ticks
closely related to L ricinus. In Australia, however, ticks have not been implicated, as
cases were acquired after the bites of unknown insects. Interestingly, in Australia,
no ticks reported to bite humans belong to the L ricinus tick complex [7]. Tlhus,
although only three closely related ticks are presently recognized as documented vec-
tors of ECM, the occurrence of a case in Sweden ascribed to the bite(s) of mos-
quitoes and the cases occurring in Australia suggest that other vectors may eventually
be described.
In Europe, shortly afterAfzelius' report, Lipschutz in 1913 described ECM occur-
ring in Austria [8]. Subsequently, ECM has been reported from all the Scandinavian
countries, England and Scotland in Great Britain, and all the countries of western
Europe, with the exception of Greece. In eastern Europe, cases have been reported
from Czechoslovakia, Romania, and Russia.
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The first case ofECM reported from the United States was acquired in Wisconsin
in 1969 [2]. It was not until 1975, however, that researchers from Yale University
School of Medicine, investigating an unusual cluster ofcases ofarthritis in Connect-
icut, again recognized ECM acquired in the United States and shortly thereafter de-
scribed the full clinical spectrum of Lyme disease [9]. Subsequently, Lyme disease
has been recognized in three broad geographical areas: the coastal areas of the
Northeast (Massachusetts to Virginia), theMidwest (Minnesota and Wisconsin), and
California, Nevada, and Oregon in the West [6,10]. These areas roughly correspond
to the recognized distribution of L dammini (in the Northeast and Midwest) and I.
pacificus (in the West). Individual cases have also been reported from Georgia [10]
and Arkansas [11], and two cases were reported from North Carolina [12]. Sim-
ilarly, unpublished individual cases meeting a clinically defined case definition were
reported in 1982 from Utah and western Pennsylvania, additional areas far removed
from recognized endemic areas [13]. For the moment, it may be prudent not to con-
sider these areas as endemic until additional cases are recognized in the areas or the
clinical diagnosis can be confirmed by serologic or culture evidence.
In Australia, in 1982, cases were reported from the Hunter Valley, north of
Sydney [3]. No cases from other areas are known to Australian health authorities
[Editor, CommunicableDiseases Intelligence-Australia: personal communication].
Whether the long time interval (more than half a century) between the first
descriptions of ECM in Europe and its recognition in North America and Australia
is due to simple lack of recognition or to spread of the organism causing Lyme
disease [14] in some unknown manner is unclear. In either event, it is likely that we
may see Lyme disease diagnosed in additional areas not currently thought to be
endemic.
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